Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
暂无分享,去创建一个
Douglas W. Thomson | David M. Wilson | Melanie V. Leveridge | G. Drewes | G. Joberty | R. Prinjha | Kevin Lee | C. Chung | R. Katso | L. Kruidenier | J. Liddle | Hawa Diallo | J. Mosley | R. Sheppard | P. Thomas | O. Singh | I. Rioja | M. Barker | F. Brown | Jack A. Brown | M. Campbell | P. Humphreys | Clement Douault | Carl P. Haslam | S. Westaway | M. Muelbaier | Alex Preston | Gail A Seal | Laurie J. Gordon | R. Eagle | Thomas G. Hayhow | Joanna Taylor | A. Rüger | Rebecca Randle
[1] David M. Wilson,et al. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives. , 2016, Journal of medicinal chemistry.
[2] Gonzalo Colmenarejo,et al. Identification and Characterization of Hundreds of Potent and Selective Inhibitors of Trypanosoma brucei Growth from a Kinase-Targeted Library Screening Campaign , 2014, PLoS neglected tropical diseases.
[3] A. Tarakhovsky,et al. Chromatin targeting drugs in cancer and immunity , 2013, Genes & development.
[4] R. Klose,et al. 5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation. , 2013, Chemical science.
[5] J. Whetstine,et al. Histone lysine methylation dynamics: establishment, regulation, and biological impact. , 2012, Molecular cell.
[6] Christopher J. Schofield,et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response , 2012, Nature.
[7] R. Klose,et al. Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases. , 2012, Journal of medicinal chemistry.
[8] C. Bountra,et al. Epigenetic protein families: a new frontier for drug discovery , 2012, Nature Reviews Drug Discovery.
[9] Melanie V. Leveridge,et al. Enabling Lead Discovery for Histone Lysine Demethylases by High-Throughput RapidFire Mass Spectrometry , 2012, Journal of biomolecular screening.
[10] S. Schreiber,et al. A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases. , 2011, Journal of the American Chemical Society.
[11] T. Heightman,et al. Inhibition of Histone Demethylases by 4‐Carboxy‐2,2′‐Bipyridyl Compounds , 2011, ChemMedChem.
[12] T. Heightman,et al. Inhibition of the histone demethylase JMJD2E by 3-substituted pyridine 2,4-dicarboxylates. , 2011, Organic & biomolecular chemistry.
[13] Makoto Hasegawa,et al. Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors. , 2010, Journal of medicinal chemistry.
[14] David M. Wilson,et al. Epigenetic control of the immune system: histone demethylation as a target for drug discovery. , 2010, Drug discovery today. Technologies.
[15] Christopher J. Schofield,et al. Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches† , 2010, Journal of medicinal chemistry.
[16] C. Schofield,et al. Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn(II). , 2009, Chemical communications.
[17] Robert A. Copeland,et al. Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.
[18] Yukihiro Itoh,et al. Synthesis and activity of N-oxalylglycine and its derivatives as Jumonji C-domain-containing histone lysine demethylase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[19] U. Oppermann,et al. Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. , 2008, Journal of medicinal chemistry.
[20] Juri Rappsilber,et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3 , 2006, Nature.
[21] P. Carmeliet,et al. Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes. , 2013, Trends in biochemical sciences.